 |
|
Peritonsillar Involvement in Pyoderma Gangrenosum associated with Ulcerative Colitis
Yu Mi Byeon, Jun Lee, Sang Jun Lee, Chol Jin Park, Na Ra Yun, Young Dae Kim, Chan Guk Park, Man Woo Kim
Intest Res. 2014;12(2):153-156. Published online 2014 Apr 29 DOI: https://doi.org/10.5217/ir.2014.12.2.153
|
|
Citations to this article as recorded by
 Biologic and small-molecule medications in the management of pyoderma gangrenosum
Fatima McKenzie, Devin Cash, Angela Gupta, Laurel W. Cummings, Alex G. Ortega-Loayza
Journal of Dermatological Treatment.2019; 30(3): 264. CrossRef Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi‐systematic review
Hakim Ben Abdallah, Karsten Fogh, Rikke Bech
International Wound Journal.2019; 16(2): 511. CrossRef Efficacy of cytapheresis for remission induction and dermatological manifestations of ulcerative colitis
Osamu Nomura, Taro Osada, Tomoyoshi Shibuya, Dai Ishikawa, Keiichi Haga, Tomohiro Kodani, Naoto Sakamoto, Tatsuo Ogihara, Ken Yamaji, Sumio Watanabe
Journal of Clinical Apheresis.2018; 33(1): 21. CrossRef Multiple Pyoderma Gangrenosum in Ulcerative Colitis
Sung Bum Kim, Si Hyung Lee
The Korean Journal of Gastroenterology.2018; 72(3): 155. CrossRef Factors Associated with Anxiety and Depression in Korean Patients with Inactive Inflammatory Bowel Disease
Min Chul Kim, Yoon Suk Jung, Young Seok Song, Jung In Lee, Jung Ho Park, Chong Il Sohn, Kyu Yong Choi, Dong Il Park
Gut and Liver.2016;[Epub] CrossRef
|